These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 29921544)

  • 1. Management of Localised Prostate Cancer in Kidney Transplant Patients: A Systematic Review from the EAU Guidelines on Renal Transplantation Panel.
    Hevia V; Boissier R; Rodríguez-Faba Ó; Fraser-Taylor C; Hassan-Zakri R; Lledo E; Regele H; Buddde K; Figueiredo A; Olsburgh J; Breda A
    Eur Urol Focus; 2018 Mar; 4(2):153-162. PubMed ID: 29921544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
    Mottet N; Bellmunt J; Bolla M; Briers E; Cumberbatch MG; De Santis M; Fossati N; Gross T; Henry AM; Joniau S; Lam TB; Mason MD; Matveev VB; Moldovan PC; van den Bergh RCN; Van den Broeck T; van der Poel HG; van der Kwast TH; Rouvière O; Schoots IG; Wiegel T; Cornford P
    Eur Urol; 2017 Apr; 71(4):618-629. PubMed ID: 27568654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-risk Prostate Cancer Prior to or After Kidney Transplantation.
    Stöckle M; Junker K; Fornara P
    Eur Urol Focus; 2018 Mar; 4(2):148-152. PubMed ID: 30005996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review.
    Lardas M; Liew M; van den Bergh RC; De Santis M; Bellmunt J; Van den Broeck T; Cornford P; Cumberbatch MG; Fossati N; Gross T; Henry AM; Bolla M; Briers E; Joniau S; Lam TB; Mason MD; Mottet N; van der Poel HG; Rouvière O; Schoots IG; Wiegel T; Willemse PM; Yuan CY; Bourke L
    Eur Urol; 2017 Dec; 72(6):869-885. PubMed ID: 28757301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose-rate brachytherapy for prostate cancer in renal transplant recipients.
    Rivero-Belenchón I; Osmán-García I; Congregado-Ruíz CB; Cabrera-Roldán P; Jiménez-Torres MJ; Baeza-Trujillo M; Lendínez-Cano G; Conde-Sánchez JM; Argüelles-Salido E; Ortiz-Gordilo MJ; Medina-López RA
    Brachytherapy; 2018; 17(5):808-815. PubMed ID: 29970298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature.
    Chade DC; Eastham J; Graefen M; Hu JC; Karnes RJ; Klotz L; Montorsi F; van Poppel H; Scardino PT; Shariat SF
    Eur Urol; 2012 May; 61(5):961-71. PubMed ID: 22280856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permanent interstitial low-dose-rate brachytherapy for patients with localised prostate cancer: a systematic review of randomised and nonrandomised controlled clinical trials.
    Peinemann F; Grouven U; Bartel C; Sauerland S; Borchers H; Pinkawa M; Heidenreich A; Lange S
    Eur Urol; 2011 Nov; 60(5):881-93. PubMed ID: 21763066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
    Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
    Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.
    Heidenreich A; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Mottet N; Schmid HP; van der Kwast T; Wiegel T; Zattoni F;
    Eur Urol; 2011 Jan; 59(1):61-71. PubMed ID: 21056534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External Beam Radiation Therapy With a Brachytherapy Boost Versus Radical Prostatectomy in Gleason Pattern 5 Prostate Cancer: A Population-Based Cohort Study.
    Wang C; Kishan AU; Kamrava M; Steinberg ML; King CR
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1045-1052. PubMed ID: 28721887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
    Mottet N; van den Bergh RCN; Briers E; Van den Broeck T; Cumberbatch MG; De Santis M; Fanti S; Fossati N; Gandaglia G; Gillessen S; Grivas N; Grummet J; Henry AM; van der Kwast TH; Lam TB; Lardas M; Liew M; Mason MD; Moris L; Oprea-Lager DE; van der Poel HG; Rouvière O; Schoots IG; Tilki D; Wiegel T; Willemse PM; Cornford P
    Eur Urol; 2021 Feb; 79(2):243-262. PubMed ID: 33172724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer treatment in renal transplant recipients: a systematic review.
    Marra G; Dalmasso E; Agnello M; Munegato S; Bosio A; Sedigh O; Biancone L; Gontero P
    BJU Int; 2018 Mar; 121(3):327-344. PubMed ID: 28921938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.
    Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
    Eur Urol; 2014 Jan; 65(1):124-37. PubMed ID: 24207135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brachytherapy for the treatment of recurrent prostate cancer after radiotherapy or radical prostatectomy.
    Gomez-Veiga F; Mariño A; Alvarez L; Rodriguez I; Fernandez C; Pertega S; Candal A
    BJU Int; 2012 Feb; 109 Suppl 1():17-21. PubMed ID: 22239225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-risk Prostate Cancer: Identification, Management, and Outcomes.
    Moschini M; Carroll PR; Eggener SE; Epstein JI; Graefen M; Montironi R; Parker C
    Eur Urol; 2017 Aug; 72(2):238-249. PubMed ID: 28318726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review.
    Fossati N; Willemse PM; Van den Broeck T; van den Bergh RCN; Yuan CY; Briers E; Bellmunt J; Bolla M; Cornford P; De Santis M; MacPepple E; Henry AM; Mason MD; Matveev VB; van der Poel HG; van der Kwast TH; Rouvière O; Schoots IG; Wiegel T; Lam TB; Mottet N; Joniau S
    Eur Urol; 2017 Jul; 72(1):84-109. PubMed ID: 28126351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryotherapy for localised prostate cancer.
    Shelley M; Wilt TJ; Coles B; Mason MD
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005010. PubMed ID: 17636783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer.
    Wolff RF; Ryder S; Bossi A; Briganti A; Crook J; Henry A; Karnes J; Potters L; de Reijke T; Stone N; Burckhardt M; Duffy S; Worthy G; Kleijnen J
    Eur J Cancer; 2015 Nov; 51(16):2345-67. PubMed ID: 26254809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.